Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Does exposure to asbestos cause prostate cancer? A systematic literature review and meta-analysis.

Peng R, Fang F, Chen Z, Yang S, Dai C, Wang C, Guan H, Li Q.

Medicine (Baltimore). 2019 Jan;98(3):e14108. doi: 10.1097/MD.0000000000014108.

2.

Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate: A population-based study.

Liu FC, Hua KC, Lin JR, Pang ST, Yu HP.

Medicine (Baltimore). 2019 Jan;98(3):e13897. doi: 10.1097/MD.0000000000013897.

3.

Acupuncture for pain caused by prostate cancer: Protocol for a systematic review.

Wang J, Lei Y, Bao B, Yu X, Dai H, Chen F, Li H, Wang B.

Medicine (Baltimore). 2019 Jan;98(2):e13954. doi: 10.1097/MD.0000000000013954. Review.

4.

Management of advanced prostate cancer: A systematic review of existing guidelines and recommendations.

Dellis A, Zagouri F, Liontos M, Mitropoulos D, Bamias A, Papatsoris AG; Hellenic Genito-Urinary Cancer Group (HCUCG).

Cancer Treat Rev. 2019 Feb;73:54-61. doi: 10.1016/j.ctrv.2018.11.005. Epub 2018 Dec 1.

PMID:
30623865
5.

PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.

Jiang Q, Xie M, He M, Yan F, Chen M, Xu S, Zhang X, Shen P.

Medicine (Baltimore). 2019 Jan;98(1):e13820. doi: 10.1097/MD.0000000000013820.

6.

Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L.

J Urol. 2019 Jan;201(1):113-119. doi: 10.1016/j.juro.2018.07.040.

PMID:
30577402
7.

PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.

Faiena I, Salmasi A, Mendhiratta N, Markovic D, Ahuja P, Hsu W, Elashoff DA, Raman SS, Reiter RE.

J Urol. 2019 Jan;201(1):91-97. doi: 10.1016/j.juro.2018.08.043.

PMID:
30577397
8.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30577395
9.

Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.

Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Andrén O, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801.

PMID:
30575473
10.

Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men.

Mahal BA, Berman RA, Taplin ME, Huang FW.

JAMA. 2018 Dec 18;320(23):2479-2481. doi: 10.1001/jama.2018.11716. No abstract available.

PMID:
30561471
11.

The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.

Zhou Y, Guan H, Fu Y, Mao L, Ge J, Liu L, Cheng L, Guan C.

Medicine (Baltimore). 2018 Dec;97(50):e13479. doi: 10.1097/MD.0000000000013479.

12.

Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.

Huang SM, Yin L, Yue JL, Li YF, Yang Y, Lin ZC.

Medicine (Baltimore). 2018 Dec;97(50):e13344. doi: 10.1097/MD.0000000000013344. Review.

13.

Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials.

Liu F, Sun D, Zhou X, Ding Y, Ma Y, Hou Y, Kong X, Wang Z.

Medicine (Baltimore). 2018 Dec;97(50):e13145. doi: 10.1097/MD.0000000000013145. Review.

15.

Is use of vitamin K antagonists associated with the risk of prostate cancer?: A meta-analysis.

Luo JD, Luo J, Lai C, Chen J, Meng HZ.

Medicine (Baltimore). 2018 Dec;97(49):e13489. doi: 10.1097/MD.0000000000013489.

16.

Prognostic indicators of outcome for patients with skeletal metastases from carcinoma of the prostate.

Shepherd KL, Cool P, Cribb G.

Bone Joint J. 2018 Dec;100-B(12):1647-1654. doi: 10.1302/0301-620X.100B12.BJJ-2018-0697.R1.

PMID:
30499326
18.

This is an older men's world: A qualitative study of men's experiences with prostate cancer.

van Ee IBB, Hagedoorn MM, Smits CHMC, Kamper AMA, Honkoop HAA, Slaets JPJJ.

Eur J Oncol Nurs. 2018 Dec;37:56-64. doi: 10.1016/j.ejon.2018.11.002. Epub 2018 Nov 3.

PMID:
30473052
19.

Health-related quality of life in patients with prostate cancer and their spouses: Results from a longitudinal study.

Harju E, Rantanen A, Helminen M, Kaunonen M, Isotalo T, Åstedt-Kurki P.

Eur J Oncol Nurs. 2018 Dec;37:51-55. doi: 10.1016/j.ejon.2018.11.001. Epub 2018 Nov 2.

PMID:
30473051
20.

Positive and negative affect and prostate cancer-specific anxiety in Taiwanese patients and their partners.

Chien CH, Chuang CK, Liu KL, Wu CT, Pang ST, Chang YH.

Eur J Oncol Nurs. 2018 Dec;37:1-11. doi: 10.1016/j.ejon.2018.09.004. Epub 2018 Oct 6.

PMID:
30473044

Supplemental Content

Loading ...
Support Center